Creative Medical Technology Holdings, Inc. (CELZ) vs FibroBiologics, Inc. Common Stock (FBLG)

A side-by-side comparison of Creative Medical Technology Holdings, Inc. and FibroBiologics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CELZ vs FBLG

growth of $100 · dividends reinvested · last 3y
CELZ -78.5% (-40.0%/yr)FBLG -99.8% (-87.3%/yr)CELZ compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020252026$22$0
CELZ FBLG

CELZ vs FBLG: by the numbers

  • •FBLG is the larger company ($3M vs $2M market cap).
  • •Both run net losses; FBLG's is the smaller (0.00% vs -201355.37% net margin).

Metrics side by side

Valuation

MetricCELZFBLG
P/S ratio774.20N/A
P/B ratio0.270.54

Profitability

MetricCELZFBLG
Gross margin63.43%0.00%
Operating margin-102380.23%0.00%
Net margin-201355.37%0.00%
ROE-69.79%-391.26%
ROIC-71.90%-286.46%

Growth (annualized)

MetricCELZFBLG
Revenue CAGR (5Y)-50.85%N/A
Total return CAGR (5Y)-57.96%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.